Home  >  Business Daily  >  Weight-loss drugs. Who pays?
Business Daily
Weight-loss drugs. Who pays?
Business Daily
Mar 2, 2026

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.

Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — are now widely prescribed for weight loss, with growing evidence they can also reduce the risk of heart disease and stroke.

But in the United States, access to GLP-1 drugs often depends on insurance coverage — and on who can afford to pay.

In this first episode of a three-part Business Daily series on the global weight-loss economy, Sam Fenwick examines the real cost of obesity drugs in the U.S. healthcare system.

How much do GLP-1 medications like Ozempic, Wegovy, Zepbound and Mounjaro actually cost? Are they cost-effective in the long term? And can insurers and employers afford to provide them to millions of Americans living with obesity?

If you’d like to get in touch with the team, our email address is [email protected]

Produced and presented by Sam Fenwick

Business Daily is the home of in-depth audio journalism devoted to the world of money and work. From small startup stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.

Each episode is a 17-minute deep dive into a single topic, featuring expert analysis and the people at the heart of the story.

Recent episodes explore the weight-loss drug revolution, the growth in AI, the cost of living, why bond markets are so powerful, China's property bubble, and Gen Z's experience of the current job market.

We also feature in-depth interviews with company founders and some of the world's most prominent CEOs.These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, CEO of Canva Melanie Perkins, and the CEO of Starbucks, Brian Niccol.

(Picture: Person standing on weighing scales. Credit: Press Association)

More Episodes
Apr 1, 2026
Is this social media's 'Big Tobacco moment'?

We look at the fallout from the recent court case which found Meta and Google liable for harming the mental health of one their young users and deliberately making their platforms addictive.

Some have suggested this is “a tobacco moment” for Big Tech – comparable to the time when cigarette companies were forced to acknowledge that their products were harmful.

We ask if social media companies should be brought into line, and if they can be. And if reforms are agreed, what would a responsible social media landscape look like?

To get in touch with the team, our email address is [email protected]

Presenter: Gideon Long Producer: Josh Martin

Business Daily is the home of in-depth audio journalism devoted to the world of money and work. From small startup stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.

Each episode is a 17-minute, daily deep dive into a single topic, featuring expert analysis and the people at the heart of the story.

Recent episodes explore the weight-loss drug revolution, the growth in AI, the cost of living, the economic impact of the war in the Middle East, and why bond markets are so powerful.

We also feature in-depth interviews with company founders and some of the world's most prominent CEOs. These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, and the CEO of Canva, Melanie Perkins.

(Picture: Left to right, Victims families and supporters Shelby Knox, Amy Neville, Mary Rodee, Laura Marquez-Garrett, Sarah Gardner, and Lennon Torres react to the verdict outside the Los Angeles Superior Court on the 25th of March 2026. Credit: Getty Images)


17min 28sec



Mar 29, 2026
After Liberation Day: Who is footing the tariffs bill?

For nearly 12 months, a raft of import duties - tariffs - have made it much more expensive to ship consumer goods into the United States. They have shaken up global trade and according to the Federal Reserve, significantly raised inflation. But who is really footing the bill for all of them?

To get in touch with the team, our email address is [email protected]

Presenter: Ed Butler Producers: Rebecca Smyllie and Craig Henderson

Business Daily is the home of in-depth audio journalism devoted to the world of money and work. From small startup stories to big corporate takeovers, global economic shifts to trends in technology, we look at the key figures, ideas and events shaping business.

Each episode is a 17-minute, daily deep dive into a single topic, featuring expert analysis and the people at the heart of the story.

Recent episodes explore the weight-loss drug revolution, the growth in AI, the cost of living, the economic impact of the war in the Middle East, and why bond markets are so powerful.

We also feature in-depth interviews with company founders and some of the world's most prominent CEOs. These include Google's Sundar Pichai, Wikipedia founder Jimmy Wales, and the CEO of Canva, Melanie Perkins.

(Photo: US President Donald Trump delivers remarks on reciprocal tariffs as US Secretary of Commerce Howard Lutnick holds a chart during a Make America Wealthy Again event at the White House, Washington DC, 2 April 2025. Credit: Getty Images)


17min 48sec

Weight-loss drugs. Who pays?

--:--
--:--